Bristol-Myers (BMY) Offers Eliquis Free to Medicaid Patients Under New Pricing Pact [Yahoo! Finance]
Bristol-Myers Squibb Company (BMY)
Last bristol-myers squibb company earnings: 2/6 07:05 am
Check Earnings Report
US:NYSE Investor Relations:
bms.com/investors.html
Company Research
Source: Yahoo! Finance
Several of the largest US and European drugmakers struck agreements with President Donald Trump on December 19 to voluntarily lower the prices of certain medicines. The move comes as the administration pushes to tie US drug prices more closely to lower costs overseas. Bristol-Myers Squibb Company (NYSE:BMY) was part of that group and one of the most notable commitments came from the company, as it said that it will provide Eliquis, its blockbuster blood thinner and most prescribed drug, free of charge to Medicaid patients. The agreement fits with the company's broader effort to improve cardiovascular care, expand patient access, and work with policymakers to reduce costs for Americans, without undercutting long-term innovation. A week earlier, on December 12, Morgan Stanley raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) to $37 from $36. The firm kept an Underweight rating on the stock. In its 2026 outlook note, the analyst said many of the policy concerns that
Show less
Read more
Impact Snapshot
Event Time:
BMY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BMY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BMY alerts
High impacting Bristol-Myers Squibb Company news events
Weekly update
A roundup of the hottest topics
BMY
News
- Bristol-Myers Squibb: Pharma Giant Still Undervalued And Printing Cash Despite Patent Cliff [Seeking Alpha]Seeking Alpha
- Bristol-Myers Squibb Surges Into Year-End: Why BMY Still Looks Undervalued [Seeking Alpha]Seeking Alpha
- Bristol-Myers Squibb: Still Undervalued And Generating 4.65% Dividend Yield [Seeking Alpha]Seeking Alpha
- Bristol Myers Squibb (NYSE:BMY) had its "buy" rating reaffirmed by analysts at Guggenheim.MarketBeat
- Bristol-Myers Squibb: Recent Gains Impress, But Tricky Tests Lie Ahead [Seeking Alpha]Seeking Alpha
BMY
Earnings
- 10/31/25 - Beat
BMY
Sec Filings
- 11/18/25 - Form 8-K
- 11/12/25 - Form CERT
- 11/10/25 - Form 8-A12B
- BMY's page on the SEC website